Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Therese Standal

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Immunity, Inflammation and Disease|September 14, 2016
Caspase-8 regulates the expression of pro- and anti-inflammatory cytokines in human bone marrow-derived mesenchymal stromal cellsSiv H Moen, Marita Westhrin, Muhammad Zahoor, et al.
British Journal of Cancer|November 29, 2022
Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survivalKristin Roseth Aass, Tonje Marie Vikene Nedal, Siri Anshushaug Bouma, et al.
Haematologica|August 22, 2015
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone diseaseMarita Westhrin, Siv Helen Moen, Toril Holien, et al.
Oncotarget|September 4, 2018
PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patientsAnne-Marit Sponaas, Rui Yang, Even Holth Rustad, et al.
Scientific Reports|February 13, 2024
Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myelomaTonje Marie Vikene Nedal, Siv Helen Moen, Ingrid Aass Roseth, et al.
Haematologica|March 9, 2004
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myelomaTherese Standal, Henrik Hjorth-Hansen, Thomas Rasmussen, et al.
Blood Advances|January 4, 2018
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone lossMuhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, et al.
Immunity, Inflammation and Disease|June 2, 2015
The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myelomaAnne M Sponaas, Siv H Moen, Nina B Liabakk, et al.
Haematologica|April 8, 2017
Monitoring multiple myeloma by quantification of recurrent mutations in serumEven Holth Rustad, Eivind Coward, Emilie R Skytøen, et al.
Blood|June 24, 2020
Monoclonal immunoglobulins promote bone loss in multiple myelomaMarita Westhrin, Vlado Kovcic, Zejian Zhang, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Immunity, Inflammation and Disease|September 14, 2016
Caspase-8 regulates the expression of pro- and anti-inflammatory cytokines in human bone marrow-derived mesenchymal stromal cellsSiv H Moen, Marita Westhrin, Muhammad Zahoor, et al.
British Journal of Cancer|November 29, 2022
Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survivalKristin Roseth Aass, Tonje Marie Vikene Nedal, Siri Anshushaug Bouma, et al.
Haematologica|August 22, 2015
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone diseaseMarita Westhrin, Siv Helen Moen, Toril Holien, et al.
Oncotarget|September 4, 2018
PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patientsAnne-Marit Sponaas, Rui Yang, Even Holth Rustad, et al.
Scientific Reports|February 13, 2024
Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myelomaTonje Marie Vikene Nedal, Siv Helen Moen, Ingrid Aass Roseth, et al.
Haematologica|March 9, 2004
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myelomaTherese Standal, Henrik Hjorth-Hansen, Thomas Rasmussen, et al.
Blood Advances|January 4, 2018
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone lossMuhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, et al.
Immunity, Inflammation and Disease|June 2, 2015
The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myelomaAnne M Sponaas, Siv H Moen, Nina B Liabakk, et al.
Haematologica|April 8, 2017
Monitoring multiple myeloma by quantification of recurrent mutations in serumEven Holth Rustad, Eivind Coward, Emilie R Skytøen, et al.
Blood|June 24, 2020
Monoclonal immunoglobulins promote bone loss in multiple myelomaMarita Westhrin, Vlado Kovcic, Zejian Zhang, et al.
Pageof 5